Last $119.43 USD
Change Today -0.54 / -0.45%
Volume 1.1M
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger William Brimblecombe Ph.D., D.Sc., F.R.C.Path., C.Biol., F.I.Biol.

Former Director, Chairman of Management Development & Compensation Committee and Member of Science & Technology Committee, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 7 different industries.

See Board Relationships
84--

Background*

Dr. Roger William Brimblecombe, Ph.D., D.Sc., F.R.C.Path., C.Biol., F.I.Biol. serves as a Partner in MVM Life Science Partners LLP. Dr. Brimblecombe serves as a Consultant to International Biopharmaceutical Companies. He serves as a Consultant Editor of Drug Discovery World. He is a respected figure in the international pharmaceutical and biotechnology industries with extensive contacts in Europe, US and Japan. Dr. Brimblecombe served as Vice President for Research & ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Former Chairman
Former Acting Executive Chairman, Acting Chief Executive Officer, Chairman of Nomination Committee, Chairman of Remuneration Committee, Chairman of pSiMedica Limited, Non Executive Chairman of pSiOncology Pte Limited and Director of pSivida Inc
Former Chairman
1990-Present
Director
1993-2010
Former Director, Chairman of Management Development & Compensation Committee and Member of Science & Technology Committee
1999-2008
Former Non-Executive Director, Member of Nomination Committee and Member of Remuneration Committee

Education*

PhD
University of Bristol
ScD
University of Bristol

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $119.43 USD -0.54

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.